Expanded Access Program for Pirtobrutinib for Participants With B-Cell Cancer
Conditions: Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Lymphocytic, Small; Lymphoma, Mantle-Cell; Waldenstrom Macroglobulinemia; Ritcher's Transformation, Syndrome Intervention: Drug: Pirtobrutinib Sponsor: Loxo Oncology, Inc. Available (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2021 Category: Research Source Type: clinical trials
Efficacy of Venetoclax in Combination With Rituximab in Waldenstr öm's Macroglobulinemia
Condition: Waldenstrom Macroglobulinemia Interventions: Drug: Venetoclax; Rituximab; Drug: DRC Sponsors: University of Ulm; Institute for Medical Informatics, Biometry and Epidemiology, University of Munich; Zentrum für Klinische Studien Ulm; AbbVie; Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 29, 2021 Category: Research Source Type: clinical trials